Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. Device Maker Cook Expands Line In Japan, Revises Techniques

This article was originally published in PharmAsia News

Executive Summary

U.S. medical device maker Cook Medical has decided to sell its wares directly to medical facilities in Japan instead of relying on sales agents as it moves to strengthen its market in the country. As part of the effort, Cook recently hired 15 medical representatives and marketers and formed a 10-person team to oversee clinical tests and shepherd products through the approval process. A new drug-eluting stent already is being tested in Japan as well as the U.S. The firm plans to begin developing for the Japanese market products already selling in the U.S. and Europe. (Click here for more - a subscription may be required

You may also be interested in...



Radiation Oncologist Stephen Hahn Wins Final Senate Confirmation As FDA Commissioner

The US Senate on a 72-18 vote approved radiation oncologist Stephen Hahn as Commissioner of the FDA on 12 December. Voting “no” were a block of liberal Democrats, including the ranking member of a key Senate health committee. Industry advocates and most senators said Hahn is an excellent choice to lead the FDA, but some fear he will not move quickly enough to ban candy flavors in vaping products favored by teens.

Iterum Anxiously Awaiting Other Results After SURE 3 Failure

Iterum’s antibiotic sulopenem missed its endpoint by the equivalent of one patient. The company believes the Phase III data could still support its NDA for urinary tract infections.

FDA Gives Sponsors A New Tool To Prove MRI-Compatibility

The US FDA has qualified a new modeling tool that could give sponsors more assurance that their products meet the agency’s expectations for MRI-compatibility.

UsernamePublicRestriction

Register

SC069406

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel